Alkermes · 2 days ago
Senior Director, New Product Planning (NPP)- Neuroscience
Greater Boston
Full-time
Hybrid
Director/Executive
$248K/yr - $273K/yr
10+ years expAlkermes is a company focused on the pharmaceutical industry, and they are seeking a Senior Director for New Product Planning in Neuroscience. This role is responsible for leading clinical development stage programs towards commercial success through market assessments and effective interactions across multiple functions.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Lead development of forward-looking strategies, market positioning and product profiles for neuroscience pipeline products by synthesizing primary and secondary inputs that inform the development and lifecycle plan
Co-lead (with development colleague) product teams through clinical development phases, working in conjunction with internal business partners (e.g. clinical, translational medicine, regulatory, research, commercial, CMC) to optimize the market value of asset
Lead commercialization readiness efforts for late-stage assets, working with commercial and development colleagues
Oversee and drive completion of NPP and market research initiatives that provide value-added insights to the pipeline programs
Track, understand, and communicate the therapeutic market trends across multiple perspectives (e.g. commercial, managed markets, clinical, and scientific)
Proactively monitor and generate insights from market developments and competitive landscape and incorporate insights into product development effort
Generate market assessments, TPPs, and early forecasts to prioritize commercial indications for products in key therapeutic areas
Qualification
Required
Bachelor's degree or equivalent; advanced science degree preferred
10+ years of pharmaceutical industry and/or consulting experience with extensive experience in commercially oriented roles, e.g. NPP, specialty pharmaceutical marketing strategy, market research
Experience in neuroscience strongly preferred
Extensive knowledge of new product development and planning/commercialization, including understanding of therapeutic markets from multiple customer perspectives (e.g., HCP, Payers, Patients) and different business perspectives (e.g., clinical, R&D, marketing)
Preferred
Strong ability to communicate, influence, and gain consensus across multiple functions (e.g. research, clinical, regulatory, translational medicine)
Leadership presence and ability to interact effectively with multiple levels of the organization
Proactive identification of opportunities and challenges and development of thoughtful action plan
Significant analytic skills, able to clearly interpret and distill scientific, clinical and commercial information
Understanding of key marketing and market research principles
Proficiency with secondary research and databases
Excellent organization, communication (written and oral) and facilitation skills
Self-motivated, builds trust easily and operates with integrity and ethics
Strong history of delivering high quality, sustainable results using skills and capabilities
Ability to work a hybrid weekly office schedule in our Waltham office
Benefits
Annual performance pay bonus
Competitive benefits package
Company
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
1001-5000 employees
H1B Sponsorship
Alkermes has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (32)
2024 (20)
2023 (21)
2022 (14)
2021 (27)
2020 (22)
Funding
Current Stage
Public CompanyTotal Funding
$250MKey Investors
Primecap Management
2017-11-20Post Ipo Equity
2014-01-13Post Ipo Equity· $250M
2011-09-16IPO
Leadership Team
Craig Hopkinson
EVP, Research and Development, CMO
Recent News
2026-01-24
2026-01-20
Company data provided by crunchbase